A20 cells

A20 cells, also called ATCC TIB-208, is a cell line originally derived from B-cell lymphoma in an old BALB/c mouse.^[1] AT20 cells are BALB/c lymphoma cells derived from spontaneous reticulum cell neoplasm.^[2] ATCC TIB-208 cells originated from B-cell lymphoma in the reticulum cell sarcoma of an elderly BALB/c mouse.^[3] A20 cells are used in medical research such as drug screening or vaccine target selection.^[4][5][6] A20 cells are also highly responsive to immunomodulatory antibodies, and are therefore used frequently in immunotherapy drug studies.^[3]